Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: A prospective observational study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Ito, Hiroyuki ^a   Mifune, Mizuo ^a   Abe, Mariko ^a   Oshikiri, Koshiro ^a   Antoku, Shinichi ^a   Takeuchi, Yuichiro ^a   Togane, Michiko ^a   Ando, Shigenori ^a   Tsugami, Emiko ^a  

^a 2 24 18 Higashikoiwa   (Japan)

Author keywords

Antihypertensive agents; Chronic kidney disease; CKD stage; Hypertension; KDIGO; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; URINARY EXCRETION;

AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84862747334     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-48     Document Type: Article

References (27)

1. Risk factors in hypertension. Kannel WB, J Cardiovasc Pharmacol 1989 13 Suppl 1 4 S10 2468976
2. Insulin resistance and hypertension in Japanese. Iimura O, Hypertens Res 1996 19 Suppl 1 1 S8 9240755
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ 1998 317 703 713 10.1136/bmj.317.7160.703 9732337
4. 10-year follow-up of intensive glucose control in type 2 diabetes. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA, N Engl J Med 2008 359 1577 1589 10.1056/NEJMoa0806470 18784090
5. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association, Diabetes Care 1989 12 573 579 2673697
6. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee, Hypertension 2003 42 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957
7. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, ESH-ESC Task Force on the Management of Arterial Hypertension, J Hypertens 2007 2007 25 1105 1187
8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators, Lancet 2000 55 253 259
9. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, The Collaborative Study Group, N Engl J Med 1993 329 1456 1462 10.1056/NEJM199311113292004 8413456
10. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators, N Engl J Med 2001 345 861 869 10.1056/NEJMoa011161 11565518
11. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group, N Engl J Med 2001 345 851 860 10.1056/NEJMoa011303 11565517
12. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P, Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group, N Engl J Med 2001 345 870 878 10.1056/NEJMoa011489 11565519
13. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Viberti G, Wheeldon NM, MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators, Circulation 2002 106 672 678 10.1161/01.CIR.0000024416.33113.0A 12163426
14. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J, Am J Kidney Dis 2000 36 646 661 10.1053/ajkd.2000.16225 10977801
15. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU, Kidney Int 2011 80 17 28 10.1038/ki.2010.483 21150873
16. Revised equations for estimated GFR from serum creatinine in Japan. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR, Am J Kidney Dis 2009 53 982 992 10.1053/j.ajkd.2008.12.034 19339088
17. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, Am J Kidney Dis 2003 41 1 12 12500213
18. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, J Diabetes Invest 2010 1 213 228
19. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW, N Engl J Med 1998 338 645 652 10.1056/NEJM199803053381003 9486993
20. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL, Ann Intern Med 1995 123 754 762 7574193
21. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S, Lancet 1998 351 1755 1762 10.1016/S0140-6736(98)04311-6 9635947
22. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, African American Study of Kidney Disease and Hypertension Study Group, JAMA 2002 288 2421 2431 10.1001/jama.288.19.2421 12435255
23. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. Joint National Committee, JAMA 1977 237 255 261 576159
24. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Futrakul N, Futrakul P, Int J Vasc Med 2011 2011 971524 21748023
25. Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Futrakul N, Kulaputana O, Futrakul P, Chavanakul A, Deekajorndech T, Ren Fail 2011 33 312 315 10.3109/0886022X.2011.560405 21401356
26. Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE, Am J Kidney Dis 2009 53 281 289 10.1053/j.ajkd.2008. 10.041 19100670
27. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H, Japanese Society of Hypertension Committee, Hypertens Res 2009 32 3 107 19300436